CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 107 filers reported holding CLOVIS ONCOLOGY INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $50,634,000 | +23.2% | 1,139,890 | 0.0% | 2.01% | +9.2% |
| Q3 2016 | $41,093,000 | +162.8% | 1,139,890 | 0.0% | 1.84% | +127.1% |
| Q2 2016 | $15,639,000 | -28.5% | 1,139,890 | 0.0% | 0.81% | -44.1% |
| Q1 2016 | $21,886,000 | -45.1% | 1,139,890 | 0.0% | 1.45% | -42.8% |
| Q4 2015 | $39,896,000 | -61.9% | 1,139,890 | 0.0% | 2.54% | -63.2% |
| Q3 2015 | $104,824,000 | +4.6% | 1,139,890 | 0.0% | 6.91% | +32.0% |
| Q2 2015 | $100,174,000 | -40.8% | 1,139,890 | -50.0% | 5.23% | -31.6% |
| Q1 2015 | $169,228,000 | +32.6% | 2,279,781 | 0.0% | 7.65% | +23.6% |
| Q4 2014 | $127,668,000 | +23.5% | 2,279,781 | 0.0% | 6.19% | +17.8% |
| Q3 2014 | $103,411,000 | +9.5% | 2,279,781 | 0.0% | 5.26% | +18.7% |
| Q2 2014 | $94,406,000 | -40.2% | 2,279,781 | 0.0% | 4.43% | -42.9% |
| Q1 2014 | $157,920,000 | +14.9% | 2,279,781 | 0.0% | 7.75% | +16.8% |
| Q4 2013 | $137,402,000 | -0.9% | 2,279,781 | 0.0% | 6.64% | +20.9% |
| Q3 2013 | $138,611,000 | -9.2% | 2,279,781 | 0.0% | 5.49% | -19.5% |
| Q2 2013 | $152,700,000 | – | 2,279,781 | – | 6.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |